Join our daily newsletter At The Bell to receive exclusive market insights
It’s that time of day to check out which companies are trending the most on HotCopper as we head into lunch – here’s the 3 most watched announcements on Thursday as at 11.30am AEST.
- Mesoblast Ltd: Mesoblast has by far captured the most attention on Thursday as the company raises $50M in an option to issue convertible notes. Shareholder reactions were mixed with most investors overall curious as to what the company might be planning with the funds. Private US-based entity SurgCenter, which is tied to NYSE-listed parents, is the major buyer.
- Larvotto Res: Larvotto has reported further high-grade intercepts of gold-antimony systems on-site the company’s Eleanora asset of interest with the headline drill hit boasting a 28m intercept grading at 5.7g/t gold equivalent of which 0.42% of the result was antimony. A series of other smaller hits were flagged, including one 3m intercept grading higher at 11g/tAuEq. Shareholder reactions were positive; the stock went up +6% intraday.
- Alterity Therapeutics: Alterity has issued notice of a trading halt on Thursday with shareholder reaction somewhat subdued once the market figured out that was for a capital raise. The stock presumably just needs more operating capital given no explanation around the raise was given (as is sometimes the case when a company is planning some major development), the company has 9.2B shares on issue.
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.
